Targeted radiation aims to zap prostate cancer with fewer side effects
NCT ID NCT07468903
First seen Mar 15, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This study is testing a more precise form of radiation therapy for prostate cancer. It aims to control the cancer while trying to reduce the common side effects that can affect urinary and sexual function. The trial will enroll 45 men with early-stage prostate cancer to see if this targeted approach is effective and safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.